Jan Mattsson

Co-Founder at Albireo Pharma, Inc.

Jan Mattsson

Jan Mattsson

Co-Founder at Albireo Pharma, Inc.

Overview
Career Highlights

Albireo AB
Biodel Inc.
Albireo Pharma, Inc.

RelSci Relationships

184

Number of Boards

2

Birthday

1965

Age

54

Relationships
RelSci Relationships are individuals Jan Mattsson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director, President & Chief Executive Officer at Albireo Pharma, Inc.

Relationship likelihood: Strong

Vice President-Development at Albireo AB

Relationship likelihood: Strong

Chief Financial & Business Officer at Entasis Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Mereo BioPharma Group Plc

Relationship likelihood: Strong

Advisor at Kymab Ltd.

Relationship likelihood: Strong

Former Secretary, Senior Vice President-Legal Affairs & General Counsel at Targacept, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer & Treasurer at Albireo Pharma, Inc.

Relationship likelihood: Strong

Executive Chairman at nLife Therapeutics SL

Relationship likelihood: Strong

Associate Professor at Karolinska Institutet

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at Perosphere, Inc.

Relationship likelihood: Strong

Paths to Jan Mattsson
Potential Connections via
Relationship Science
You
Jan Mattsson
Co-Founder at Albireo Pharma, Inc.
Education
Ph.D., Biochemistry

University of Gothenburg is a school in Gothenburg.

Career History
Chief Operating Officer
2008 - Current

Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden.

Co-Founder
2003 - Current

Albireo Pharma, Inc. is a pharmaceutical company, which engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its product pipeline includes A4250, Elobixibat, and A3384. The company was founded by Jan Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Chief Operating Officer
Tenure Unconfirmed

Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT.

Boards & Committees
Director
2013 - Current

Elobix AB, a subsidiary of Albireo Pharma, Inc., is a Swedish company located in Gothenburg that provides commercial physical research services.

Chief Executive Officer, Chief Operating Officer & Director
2008 - Prior

Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.

Investments
Details Hidden

Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.

Details Hidden
Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jan Mattsson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jan Mattsson's profile does not indicate a business or promotional relationship of any kind between RelSci and Jan Mattsson.